Apple Watch Sequence 11 receives FDA clearance for hypertension alerts

Apple’s Awe Dropping event began with dramatic health testimonials from Apple Watch customers, then revealed a key new function for the brand new Watch Sequence 11: hypertension alerts. The perform had but to obtain FDA clearance on the time, however that has now been granted, as first reported by Bloomberg and confirmed by Apple. In consequence, it should reportedly be accessible to customers in 150 nations when the Watch 11 and Extremely Watch 3 ship beginning on September 19.

Hypertension alerts may help detect hypertension (hypertension), a doubtlessly harmful situation that impacts over a billion folks. The function depends on the Watch’s optical coronary heart sensor, however now makes use of new machine studying algorithm that additionally attracts from a examine involving greater than 100,000 contributors to search for hypertension. It really works within the background a month-long interval to hunt patterns related to hypertension. In contrast to units that measure your specific blood pressure, it solely tells customers that there could also be a hazard.

Final 12 months, Apple obtained FDA clearance for its over-the-counter Hearing Aid function that transforms the second-gen AirPods Pro into OTC listening to aids for folks with mild-to-moderate listening to loss. One other lately accepted function is sleep apnea detection. Nevertheless, the corporate is at the moment facing a lawsuit over the Apple Watch’s redesigned blood oxygen monitoring function.

Correction, September 15, 2025, 10:27AM ET: This text and its headline initially acknowledged that the Apple Watch obtained FDA approval for the brand new hypertension alerts function. It obtained FDA clearance, which is a decrease stage of authorization in comparison with FDA approval. We apologize for this error.